153 related articles for article (PubMed ID: 9514091)
1. Association of fibroblastoid features with the invasive phenotype in human bronchial cancer cell lines.
Polette M; Gilles C; de Bentzmann S; Gruenert D; Tournier JM; Birembaut P
Clin Exp Metastasis; 1998 Feb; 16(2):105-12. PubMed ID: 9514091
[TBL] [Abstract][Full Text] [Related]
2. MT1-MMP correlates with MMP-2 activation potential seen after epithelial to mesenchymal transition in human breast carcinoma cells.
Pulyaeva H; Bueno J; Polette M; Birembaut P; Sato H; Seiki M; Thompson EW
Clin Exp Metastasis; 1997 Mar; 15(2):111-20. PubMed ID: 9062387
[TBL] [Abstract][Full Text] [Related]
3. E-Cadherin mediates MMP down-regulation in highly invasive bronchial tumor cells.
Nawrocki-Raby B; Gilles C; Polette M; Martinella-Catusse C; Bonnet N; Puchelle E; Foidart JM; Van Roy F; Birembaut P
Am J Pathol; 2003 Aug; 163(2):653-61. PubMed ID: 12875984
[TBL] [Abstract][Full Text] [Related]
4. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma.
Gilles C; Polette M; Seiki M; Birembaut P; Thompson EW
Lab Invest; 1997 May; 76(5):651-60. PubMed ID: 9166284
[TBL] [Abstract][Full Text] [Related]
5. Role of tissue inhibitor of metalloproteinases-2 (TIMP-2) in regulation of pro-gelatinase A activation catalyzed by membrane-type matrix metalloproteinase-1 (MT1-MMP) in human cancer cells.
Shofuda K; Moriyama K; Nishihashi A; Higashi S; Mizushima H; Yasumitsu H; Miki K; Sato H; Seiki M; Miyazaki K
J Biochem; 1998 Aug; 124(2):462-70. PubMed ID: 9685743
[TBL] [Abstract][Full Text] [Related]
6. MMP-9 secretion and MMP-2 activation distinguish invasive and metastatic sublines of a mouse mammary carcinoma system showing epithelial-mesenchymal transition traits.
Tester AM; Ruangpanit N; Anderson RL; Thompson EW
Clin Exp Metastasis; 2000; 18(7):553-60. PubMed ID: 11688960
[TBL] [Abstract][Full Text] [Related]
7. Down-Regulation of MT1-MMP expression by the alpha3 chain of type IV collagen inhibits bronchial tumor cell line invasion.
Martinella-Catusse C; Polette M; Noel A; Gilles C; Dehan P; Munaut C; Colige A; Volders L; Monboisse JC; Foidart JM; Birembaut P
Lab Invest; 2001 Feb; 81(2):167-75. PubMed ID: 11232638
[TBL] [Abstract][Full Text] [Related]
8. Induction of membrane-type matrix metalloproteinase 1 (MT1-MMP) expression in human fibroblasts by breast adenocarcinoma cells.
Polette M; Gilles C; Marchand V; Seiki M; Tournier JM; Birembaut P
Clin Exp Metastasis; 1997 Mar; 15(2):157-63. PubMed ID: 9062392
[TBL] [Abstract][Full Text] [Related]
9. Quantitative cell dispersion analysis: new test to measure tumor cell aggressiveness.
Nawrocki Raby B; Polette M; Gilles C; Clavel C; Strumane K; Matos M; Zahm JM; Van Roy F; Bonnet N; Birembaut P
Int J Cancer; 2001 Sep; 93(5):644-52. PubMed ID: 11477573
[TBL] [Abstract][Full Text] [Related]
10. Epithelial-to-mesenchymal transition in HPV-33-transfected cervical keratinocytes is associated with increased invasiveness and expression of gelatinase A.
Gilles C; Polette M; Piette J; Birembaut P; Foidart JM
Int J Cancer; 1994 Dec; 59(5):661-6. PubMed ID: 7960239
[TBL] [Abstract][Full Text] [Related]
11. Expression of c-ets-1 mRNA is associated with an invasive, EMT-derived phenotype in breast carcinoma cell lines.
Gilles C; Polette M; Birembaut P; Brünner N; Thompson EW
Clin Exp Metastasis; 1997 Sep; 15(5):519-26. PubMed ID: 9247254
[TBL] [Abstract][Full Text] [Related]
12. Membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation in primary human ovarian epithelial carcinoma cells.
Fishman DA; Bafetti LM; Stack MS
Invasion Metastasis; 1996; 16(3):150-9. PubMed ID: 9186550
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of matrix metalloproteinase-2 activation in human breast cancer cell lines.
Maiti SN; Yu M; Bueno J; Tirgari RH; Palao-Marco FL; Pulyaeva H; Thompson EW
Ann N Y Acad Sci; 1994 Sep; 732():456-8. PubMed ID: 7978838
[No Abstract] [Full Text] [Related]
14. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
Yamamoto M; Mohanam S; Sawaya R; Fuller GN; Seiki M; Sato H; Gokaslan ZL; Liotta LA; Nicolson GL; Rao JS
Cancer Res; 1996 Jan; 56(2):384-92. PubMed ID: 8542596
[TBL] [Abstract][Full Text] [Related]
15. Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells.
Yu M; Sato H; Seiki M; Thompson EW
Cancer Res; 1995 Aug; 55(15):3272-7. PubMed ID: 7614461
[TBL] [Abstract][Full Text] [Related]
16. Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production.
Azzam HS; Arand G; Lippman ME; Thompson EW
J Natl Cancer Inst; 1993 Nov; 85(21):1758-64. PubMed ID: 8411260
[TBL] [Abstract][Full Text] [Related]
17. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion.
Di Nezza LA; Misajon A; Zhang J; Jobling T; Quinn MA; Ostör AG; Nie G; Lopata A; Salamonsen LA
Cancer; 2002 Mar; 94(5):1466-75. PubMed ID: 11920503
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine phosphorylation mediates ConA-induced membrane type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in MDA-MB-231 human breast carcinoma cells.
Yu M; Bowden ET; Sitlani J; Sato H; Seiki M; Mueller SC; Thompson EW
Cancer Res; 1997 Nov; 57(22):5028-32. PubMed ID: 9371497
[TBL] [Abstract][Full Text] [Related]
19. Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface.
Lehti K; Lohi J; Valtanen H; Keski-Oja J
Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):345-53. PubMed ID: 9716492
[TBL] [Abstract][Full Text] [Related]
20. Increased invasion and matrix metalloproteinase-2 expression by Snail-induced mesenchymal transition in squamous cell carcinomas.
Yokoyama K; Kamata N; Fujimoto R; Tsutsumi S; Tomonari M; Taki M; Hosokawa H; Nagayama M
Int J Oncol; 2003 Apr; 22(4):891-8. PubMed ID: 12632084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
